Abnormalities in this pathway exacerbate tau pathology, another critical aspect of AD characterized by the hyperphosphorylation and aggregation of tau protein (Garcia et al., 2021; Hou et al., 2020). This evidence concerns the gene MAPT and Alzheimer disease.